TrialEuropean heart journal. Cardiovascular pharmacotherapy2025

Polygenic risk, aspirin, and primary prevention of coronary artery disease.

Chenglong Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.